KALV
KalVista Pharmaceuticals, Inc. · Healthcare
Venrock Healthcare Capital Partners Iii, L.P. bought $6.5M of KalVista Pharmaceuticals, Inc.
10% owner
Bought$6,465,650
$12.46Price
519,017Shares
+15%Stake
What KALV did for a copier
- $1,000 copied at Tue, Jan 2 open, $12.53
- $1,149
- S&P 500, same days
- +5.6%
Measured over 30 trading days, to the Feb 14 close.
Venrock Healthcare Capital Partners Iii, L.P.'s record
13 other buys with 3 months of prices since 2020: on average −2.8% against the S&P 500, and 5 of 13 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Dec 27. Filed Fri, Dec 29, 6:44 PM ET, after the close. Returns use the Jan 2 open and the Feb 14 close. Not investment advice.